BioLab said its distribution center was cleared by relevant authorities and regulators to reopen on November 4. It is not manufacturing any new products.
India should focus on enhancing local vaccine manufacturing and research for better control over safety, according to GTRI. They also suggest investigating adverse health events post-vaccination to ...